When Good Intentions Are Not Enough: Ethical Tensions in Rare Disease Care in Indonesia

Authors

  • Ardita H. Pramudani Community Genetics Research Center & Department of Forensics and Medicolegal, Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia https://orcid.org/0000-0002-8547-0807
  • Ika Septiana Eryani Center for Health Financing, Secretariat General, Ministry of Health, Semarang, Central Java, Indonesia https://orcid.org/0009-0008-6184-2785
  • Agustini Utari Community Genetics Research Center & Department of Pediatrics, Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia https://orcid.org/0000-0001-5965-1981
  • Tri Indah Winarni Department of Pediatrics, Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia https://orcid.org/0000-0001-5450-2813

DOI:

https://doi.org/10.7202/1126629ar

Keywords:

Indonesia, solidarity, beneficence, justice, rare disease

Language(s):

English

Abstract

This case study examines a child with a rare genetic condition in Indonesia whose access to care depended on community mobilization in the context of limited institutional support, revealing a tension between the principles of beneficence and justice in resource-constrained health systems. While acts of beneficence are morally commendable, we argue that justice should take priority by motivating equitable, institutional solutions that avoid reliance on ad hoc community goodwill and prevent unequal access to care among patients with comparable needs.

References

1. Shafie AA, Chaiyakunapruk N, Supian A, et al. State of rare disease management in Southeast Asia. Orphanet J Rare Dis. 2016;11:107.

2. Utari A, Faradz SMH, Ediati A, et al. Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country. Front Endocrinol. 2022;13:1015973.

3. Sari JI, Pramudani AH, Ediati A, Utari A. Caring for girls with salt-wasting congenital adrenal hyperplasia: A qualitative study from Central Java, Indonesia. J Pediatr Health Care. 2025;40(3):e38-47.

4. Mascarenhas JV, Ayyar VS. Russell Silver syndrome: a perspective on growth and the influence of growth hormone therapy. Indian J Endocrinol Metab. 2012;16(5):840-2.

5. Piekoszewska-Ziętek P, Witt-Porczyk A, Chrzanowska K, Zadurska M, Kowalczyk DO. Silver-Russell syndrome: phenotype features and oral health status. Orphanet Journal of Rare Diseases. 2025;20:370.

6. Ariani Y, Soeharso P, Sjarif DR. Genetics and genomic medicine in Indonesia. Mol Genet Genomic Med. 2017;5(2):103-9.

7. Budiastrawan IPA. Keluarga Tak Mampu, Yahya Terpaksa Enam Bulan Tidak Berobat. detikbali. 18 Jan 2023.

8. Prainsack B, Buyx A. Solidarity in Biomedicine and Beyond. Cambridge: Cambridge University Press; 2017.

9. Susilo D, Wulandari LPL, Sukmayeti E, et al. Can Indonesia achieve universal health coverage? Organisational and financing challenges in implementing the national health insurance system. SSM - Health Systems. 2025;5:100138.

10. Sambodo NP, Van Doorslaer E, Pradhan M, Sparrow R. Does geographic spending variation exacerbate healthcare benefit inequality? A benefit incidence analysis for Indonesia. Health Policy Plan. 2021;36(7):1129-39.

11. Mulyanto J, Kringos DS, Kunst AE. Socioeconomic inequalities in healthcare utilisation in Indonesia: A comprehensive survey-based overview. BMJ Open. 2019;9(7):e026164.

12. World Population Dashboard. Indonesia Population 2025. United Nations Population Fund.

13. Cornish F. Genomics 101: What is the diagnostic odyssey? Genomics England. 15 Jan 2025.

Downloads

Published

2026-06-22

How to Cite

[1]
Pramudani AH, Eryani IS, Utari A, Winarni TI. When Good Intentions Are Not Enough: Ethical Tensions in Rare Disease Care in Indonesia. Can. J. Bioeth 2026;9:128-30. https://doi.org/10.7202/1126629ar.

Issue

Section

Case studies